$8.8B Sigma, Chemist Warehouse merger raises competition concerns: ACCC
Competition & Consumer Protection 2024-06-13 2:16 pm By Andy Sidler | Melbourne
Please login to bookmark Close

The ACCC has flagged competition concerns about drug supplier Sigma Healthcare’s proposed $8.8 billion reverse merger with Chemist Warehouse, saying the tie-up could harm independent pharmacies and lessen competition in pharmacy retail.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au